Yonghao Jin

Yonghao Jin

UNVERIFIED PROFILE

Are you Yonghao Jin?   Register this Author

Register author
Yonghao Jin

Yonghao Jin

Publications by authors named "Yonghao Jin"

Are you Yonghao Jin?   Register this Author

11Publications

-Reads

ATAC-pipe: general analysis of genome-wide chromatin accessibility.

Brief Bioinform 2018 Jun 29. Epub 2018 Jun 29.

Hefei National Laboratory for Physical Sciences at Microscale, the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences, University of Science and Technology of China, Hefei 230027, China.

View Article
June 2018

A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis.

PLoS One 2017 24;12(2):e0172925. Epub 2017 Feb 24.

Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida, United States of America.

View Article
August 2017

Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.

Cancer Cell 2017 07 15;32(1):27-41.e4. Epub 2017 Jun 15.

Center for Personal Dynamic Regulomes and Program in Epithelial Biology, Stanford University School of Medicine, CCSR 2155c, 269 Campus Drive, Stanford, CA 94305-5168, USA; Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address:

View Article
July 2017

Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.

J Med Chem 2013 Jun 16;56(11):4357-73. Epub 2013 May 16.

Department of Chemistry and Biochemistry and Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida, USA.

View Article
June 2013

Enhancing QM/MM molecular dynamics sampling in explicit environments via an orthogonal-space-random-walk-based strategy.

J Phys Chem B 2011 Apr 21;115(14):3924-35. Epub 2011 Mar 21.

Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida 32306, USA.

View Article
April 2011

Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases.

Curr Top Med Chem 2006 ;6(4):289-316

Department of Chemistry and Biochemistry and Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306-4390, USA.

View Article
August 2006

Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.

Biochem J 2005 Dec;392(Pt 3):527-36

Department of Chemistry and Biochemistry and Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306-4390, USA.

View Article
December 2005

Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.

Biochem J 2004 Feb;377(Pt 3):775-9

Department of Chemistry and Biochemistry and Institute of Molecular Biophysics, 203 Dittmer Laboratory of Chemistry Building, Florida State University, Tallahassee, FL 32306, U.S.A.

View Article
February 2004

The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.

J Biol Chem 2003 Dec 7;278(51):51646-53. Epub 2003 Oct 7.

Department of Chemistry and Biochemistry and Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida 32306-4390, USA.

View Article
December 2003

Origin of the stereospecificity in binding hydroxamates of alpha- and beta-phenylalanine methylamide to thermolysin revealed by the X-ray crystallographic study.

Bioorg Med Chem 2003 May;11(11):2421-6

Center for Cellular Switch Protein Structure, Korea Research Institute of Bioscience and Biotechnology, 52 Euh-eun-dong, Yusong-gu, 305-806, Deajeon, South Korea.

View Article
May 2003

Enzymatic properties of rat myelencephalon-specific protease.

Biochemistry 2002 Jan;41(4):1165-73

Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida 32306-4380, USA.

View Article
January 2002